Finley Aidan, Copeland Robert A
Epizyme, Inc., 400 Technology Square, 4th Floor, Cambridge, MA 02139, USA.
Epizyme, Inc., 400 Technology Square, 4th Floor, Cambridge, MA 02139, USA.
Chem Biol. 2014 Sep 18;21(9):1196-210. doi: 10.1016/j.chembiol.2014.07.024.
Control of cellular transcriptional programs is based on reversible changes in chromatin conformation that affect access of the transcriptional machinery to specific gene promoters. Chromatin conformation is in turn controlled by the concerted effects of reversible, covalent modification of the DNA and histone components of chromatin, along with topographical changes in DNA-histone interactions; all of these chromatin-modifying reactions are catalyzed by specific enzymes and are communicated to the transcriptional machinery by proteins that recognize and bind to unique, covalent modifications at specific chromatin sites (so-called reader proteins). Over the past decade, considerable progress has been made in the discovery of potent and selective small molecule modulators of specific chromatin-modifying proteins. Here we review the progress that has been made toward small molecule control of these mechanisms and the potential clinical applications of such small molecule modulators of chromatin remodeling.
细胞转录程序的调控基于染色质构象的可逆变化,这种变化会影响转录机制对特定基因启动子的 access。染色质构象又反过来由染色质的 DNA 和组蛋白成分的可逆共价修饰的协同效应以及 DNA-组蛋白相互作用的拓扑变化所控制;所有这些染色质修饰反应均由特定酶催化,并通过识别并结合特定染色质位点独特共价修饰的蛋白质(所谓的 reader 蛋白)传递给转录机制。在过去十年中,在发现特定染色质修饰蛋白的强效和选择性小分子调节剂方面取得了相当大的进展。在此,我们综述了在这些机制的小分子控制方面所取得的进展以及此类染色质重塑小分子调节剂的潜在临床应用。